Cargando…
Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population
BACKGROUND: The aim of this study was to investigate the genomic alterations of renal cell carcinoma (RCC) in Chinese patients and to evaluate the correlations between significantly mutated genes and tumor mutation burden (TMB) levels in RCC. MATERIAL/METHODS: Two batch of specimens were collected f...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489529/ https://www.ncbi.nlm.nih.gov/pubmed/31007253 http://dx.doi.org/10.12659/MSM.914493 |
_version_ | 1783414838182019072 |
---|---|
author | Zhang, Shudong Wang, Binshuai Zhang, Fan Ye, Jianfei Ge, Liyuan Ma, Lulin |
author_facet | Zhang, Shudong Wang, Binshuai Zhang, Fan Ye, Jianfei Ge, Liyuan Ma, Lulin |
author_sort | Zhang, Shudong |
collection | PubMed |
description | BACKGROUND: The aim of this study was to investigate the genomic alterations of renal cell carcinoma (RCC) in Chinese patients and to evaluate the correlations between significantly mutated genes and tumor mutation burden (TMB) levels in RCC. MATERIAL/METHODS: Two batch of specimens were collected from patients with RCC. Cohort 1 enrolled 17 RCC patients. Specimens and clinicopathological data were collected and the duration of disease-free survival were evaluated with a follow-up from 2 weeks to longer than 1 year. Cohort 2 collected 70 clear cell RCC (ccRCC) tissues and blood specimens. Next-generation sequencing were used to detect the genomic variations in those specimens in both cohorts and TMB in cohort 2. Clinicopathological features of the 2 cohorts were collected and the χ(2) test or Fisher’s exact test was used for categorical variables stratified by TMB values. RESULTS: Our present study demonstrated that the top 3 most frequent aberrated genes in Chinese ccRCC patients were ABCB1, UGT1A1, and VHL, with percentages of 50.00%, 42.86%, and 34.52% respectively. And only 1 gene, which was ABCB1, showed statistically significant difference (P=0.047) stratified by TMB levels. In addition, 6 oncogenic pathways were involved in ccRCC cases in the 2 cohorts. Only 5 out of the 8 most common altered genes of RCC from COSMIC or TCGA databases were detected in our study. CONCLUSIONS: The genomic alterations of Chinese RCC patients were different from that in TCGA and COSMIC. No significant genomic alterations were found correlating to TMB levels in ccRCC. Non-silent mutation of VHL may be a predictor for the outcome of ccRCC treated with axitinib. |
format | Online Article Text |
id | pubmed-6489529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64895292019-05-03 Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population Zhang, Shudong Wang, Binshuai Zhang, Fan Ye, Jianfei Ge, Liyuan Ma, Lulin Med Sci Monit Clinical Research BACKGROUND: The aim of this study was to investigate the genomic alterations of renal cell carcinoma (RCC) in Chinese patients and to evaluate the correlations between significantly mutated genes and tumor mutation burden (TMB) levels in RCC. MATERIAL/METHODS: Two batch of specimens were collected from patients with RCC. Cohort 1 enrolled 17 RCC patients. Specimens and clinicopathological data were collected and the duration of disease-free survival were evaluated with a follow-up from 2 weeks to longer than 1 year. Cohort 2 collected 70 clear cell RCC (ccRCC) tissues and blood specimens. Next-generation sequencing were used to detect the genomic variations in those specimens in both cohorts and TMB in cohort 2. Clinicopathological features of the 2 cohorts were collected and the χ(2) test or Fisher’s exact test was used for categorical variables stratified by TMB values. RESULTS: Our present study demonstrated that the top 3 most frequent aberrated genes in Chinese ccRCC patients were ABCB1, UGT1A1, and VHL, with percentages of 50.00%, 42.86%, and 34.52% respectively. And only 1 gene, which was ABCB1, showed statistically significant difference (P=0.047) stratified by TMB levels. In addition, 6 oncogenic pathways were involved in ccRCC cases in the 2 cohorts. Only 5 out of the 8 most common altered genes of RCC from COSMIC or TCGA databases were detected in our study. CONCLUSIONS: The genomic alterations of Chinese RCC patients were different from that in TCGA and COSMIC. No significant genomic alterations were found correlating to TMB levels in ccRCC. Non-silent mutation of VHL may be a predictor for the outcome of ccRCC treated with axitinib. International Scientific Literature, Inc. 2019-04-22 /pmc/articles/PMC6489529/ /pubmed/31007253 http://dx.doi.org/10.12659/MSM.914493 Text en © Med Sci Monit, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Clinical Research Zhang, Shudong Wang, Binshuai Zhang, Fan Ye, Jianfei Ge, Liyuan Ma, Lulin Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population |
title | Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population |
title_full | Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population |
title_fullStr | Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population |
title_full_unstemmed | Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population |
title_short | Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population |
title_sort | genomic alterations of renal cell carcinoma and clinical implications in the chinese population |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489529/ https://www.ncbi.nlm.nih.gov/pubmed/31007253 http://dx.doi.org/10.12659/MSM.914493 |
work_keys_str_mv | AT zhangshudong genomicalterationsofrenalcellcarcinomaandclinicalimplicationsinthechinesepopulation AT wangbinshuai genomicalterationsofrenalcellcarcinomaandclinicalimplicationsinthechinesepopulation AT zhangfan genomicalterationsofrenalcellcarcinomaandclinicalimplicationsinthechinesepopulation AT yejianfei genomicalterationsofrenalcellcarcinomaandclinicalimplicationsinthechinesepopulation AT geliyuan genomicalterationsofrenalcellcarcinomaandclinicalimplicationsinthechinesepopulation AT malulin genomicalterationsofrenalcellcarcinomaandclinicalimplicationsinthechinesepopulation |